Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

516 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Use of in-house studies of molecular epidemiology and full species identification for controlling spread of vancomycin-resistant Enterococcus faecalis isolates.
Bodnar UR, Noskin GA, Suriano T, Cooper I, Reisberg BE, Peterson LR. Bodnar UR, et al. Among authors: cooper i. J Clin Microbiol. 1996 Sep;34(9):2129-32. doi: 10.1128/JCM.34.9.2129-2132.1996. J Clin Microbiol. 1996. PMID: 8862571 Free PMC article.
Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces.
Noskin GA, Stosor V, Cooper I, Peterson LR. Noskin GA, et al. Among authors: cooper i. Infect Control Hosp Epidemiol. 1995 Oct;16(10):577-81. doi: 10.1086/647011. Infect Control Hosp Epidemiol. 1995. PMID: 8568202
Activity of twenty-one antimicrobial agents including l-ofloxacin against quinolone-sensitive and -resistant, and methicillin-sensitive and -resistant Staphylococcus aureus.
Peterson LR, Cooper I, Willard KE, Fasching CE, Sinn LM, Shanholtzer CJ, Gerding DN. Peterson LR, et al. Among authors: cooper i. Chemotherapy. 1994 Jan-Feb;40(1):21-5. doi: 10.1159/000239165. Chemotherapy. 1994. PMID: 8306811
Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria.
Charrier C, Salisbury AM, Savage VJ, Duffy T, Moyo E, Chaffer-Malam N, Ooi N, Newman R, Cheung J, Metzger R, McGarry D, Pichowicz M, Sigerson R, Cooper IR, Nelson G, Butler HS, Craighead M, Ratcliffe AJ, Best SA, Stokes NR. Charrier C, et al. Among authors: cooper ir. Antimicrob Agents Chemother. 2017 Apr 24;61(5):e02100-16. doi: 10.1128/AAC.02100-16. Print 2017 May. Antimicrob Agents Chemother. 2017. PMID: 28223393 Free PMC article.
In vitro biological evaluation of novel broad-spectrum isothiazolone inhibitors of bacterial type II topoisomerases.
Charrier C, Salisbury AM, Savage VJ, Moyo E, Forward H, Ooi N, Cheung J, Metzger R, McGarry D, Walker R, Cooper IR, Ratcliffe AJ, Stokes NR. Charrier C, et al. Among authors: cooper ir. J Antimicrob Chemother. 2016 Oct;71(10):2831-9. doi: 10.1093/jac/dkw228. Epub 2016 Jun 26. J Antimicrob Chemother. 2016. PMID: 27353465
Design, synthesis and antibacterial properties of pyrimido[4,5-b]indol-8-amine inhibitors of DNA gyrase.
McGarry DH, Cooper IR, Walker R, Warrilow CE, Pichowicz M, Ratcliffe AJ, Salisbury AM, Savage VJ, Moyo E, Maclean J, Smith A, Charrier C, Stokes NR, Lindsay DM, Kerr WJ. McGarry DH, et al. Among authors: cooper ir. Bioorg Med Chem Lett. 2018 Sep 15;28(17):2998-3003. doi: 10.1016/j.bmcl.2018.05.049. Epub 2018 May 26. Bioorg Med Chem Lett. 2018. PMID: 30122228
Discovery and structure-activity relationships of a novel isothiazolone class of bacterial type II topoisomerase inhibitors.
Cooper IR, McCarroll AJ, McGarry D, Kirkham J, Pichowicz M, Walker R, Warrilow C, Salisbury AM, Savage VJ, Moyo E, Forward H, Cheung J, Metzger R, Gault Z, Nelson G, Hughes D, Cao S, Maclean J, Charrier C, Craighead M, Best S, Stokes NR, Ratcliffe AJ. Cooper IR, et al. Bioorg Med Chem Lett. 2016 Sep 1;26(17):4179-83. doi: 10.1016/j.bmcl.2016.07.061. Epub 2016 Jul 28. Bioorg Med Chem Lett. 2016. PMID: 27499455
516 results
Jump to page
Feedback